| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |